aoncology.com (AONC) - Cash per Single Share

Symbol and logo of brand American Oncology Network Inc (AONC)

American Oncology Network (AONC) maintains a rhythmic capital turnover to fund growth and cover medical expenses. The business focuses on the outpatient segment, where demand is rising due to the complexity of therapy. A steady patient inflow ensures revenue predictability. The change in cash per share demonstrates current liquidity, with the 10.90 mark recording this metric, confirming the company's financial stability.

American Oncology Network, Inc. (AONC): Cash Funds per Share from 02/21/2024 to 08/04/2024

Analytical breakdowns for American Oncology Network

- cash and cash flow data:
Comprehensive company analysis:American Oncology Network, Inc. AONC
Flagship merchandise of American Oncology Network, Inc.

Cash per share reflects the issuer's actual liquidity available for meeting obligations or funding growth. By analyzing the cash per share history, an investor observes the ratio of total cash holdings to the number of outstanding shares. This indicator measures the amount of defensive capital, excluding market revaluation. For American Oncology Network (AONC), this metric indicates the network's ability to expand access to high-tech oncological care across regions. Steady growth in this metric confirms the brand's financial stability during the scaling of its clinics.

Key competitors

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash on Hand per Share Citius Oncology|HURA: Cash per Share|Cash Money per Share TARA (Protara)|FATE (fatetherapeutics.com) - Cash per Share|Cash on Hand per Share Aadi Bioscience WHWK|Cash per Share TCRX|CSBR - Cash on Hand per Share|XBiotech - Cash per Single Share|CEL-SCI Corporation (CVM) - Cash on Hand per Share|OSTX - Cash Funds per Share|Cash on Hand per Share Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Cash per Single Share|ANL (Adlai Nortye Ltd) - Cash Funds per Share|Cash per Single Share VERU|Tempest Therapeutics (TPST) - Cash Funds Calculated per Share|Cash per Share XLO|Cash per Single Share Renovaro RENB|Cash per Share MURA (Mural Oncology PLC)|KAPA - Cash per Single Share|OnKure Therapeutics - Cash per Share|w2.cytomed.sg - Cash Calculated per Single Share|Curis Corp (CRIS) - Cash Funds per Share|Cash on Hand per Share Apollomics Corp (APLM)|Cash Funds per Share Tharimmune|Cash per Share advanbiomed.com|Cash Funds per Share Genprex, Inc (GNPX)|Cash Funds Calculated per Share Calidi Biotherapeutics, Inc.|Cash per Share SBFM (Sunshine Biopharma Inc.)|XBIO - Cash per Single Share|SLRX: Cash per Single Share|Amount of Cash per Share PPBT (Purple Biotech Ltd.)|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com